Of note, significantly increased levels of the platelet surface markers GP1BA and integrin ITGB3 and the activation marker PCAM1 were common in EV preparations from both PDM and T2DM groups (Figure 6A–D). The gene discussed is ITGB3; the disease is type 2 diabetes mellitus.